000 01372 a2200385 4500
005 20250516110231.0
264 0 _c20130205
008 201302s 0 0 eng d
022 _a1520-4804
024 7 _a10.1021/jm300915b
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHewings, David S
245 0 0 _aProgress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cNov 2012
300 _a9393-413 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAcetylation
650 0 4 _aAnimals
650 0 4 _aHistones
_xmetabolism
650 0 4 _aHumans
650 0 4 _aLysine
_xmetabolism
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aNuclear Proteins
_xantagonists & inhibitors
650 0 4 _aProtein Binding
650 0 4 _aProtein Processing, Post-Translational
700 1 _aRooney, Timothy P C
700 1 _aJennings, Laura E
700 1 _aHay, Duncan A
700 1 _aSchofield, Christopher J
700 1 _aBrennan, Paul E
700 1 _aKnapp, Stefan
700 1 _aConway, Stuart J
773 0 _tJournal of medicinal chemistry
_gvol. 55
_gno. 22
_gp. 9393-413
856 4 0 _uhttps://doi.org/10.1021/jm300915b
_zAvailable from publisher's website
999 _c22054330
_d22054330